Display options
Cite
Tuomilehto J. Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?. Nat Clin Pract Endocrinol Metab. 2007;3(3):212-3doi: 10.1038/ncpendmet0422.
Tuomilehto, J. (2007). Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?. Nature clinical practice. Endocrinology & metabolism, 3(3), 212-3. https://doi.org/10.1038/ncpendmet0422
Tuomilehto, Jaakko. "Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?." Nature clinical practice. Endocrinology & metabolism vol. 3,3 (2007): 212-3. doi: https://doi.org/10.1038/ncpendmet0422
Tuomilehto J. Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?. Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):212-3. doi: 10.1038/ncpendmet0422. Epub 2007 Jan 30. PMID: 17262066.
Copy Download .nbib Format: NLM
Share it on

Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):212-3. doi: 10.1038/ncpendmet0422. Epub 2007 Jan 30.

Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?.

Nature clinical practice. Endocrinology & metabolism

Jaakko Tuomilehto

Affiliations

  1. Department of Public Health, University of Helsinki, Helsinki, Finland. [email protected]

PMID: 17262066 DOI: 10.1038/ncpendmet0422

[No abstract available.]

Publication Types